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  During the past few years, there have been growing interests in business development of herbal 
supplements in many developing countries especially in Iran. Herbal supplements are used to 
cure many deceases such as medicating anxiety, acne, weight loss, depression, etc. In this 
paper, we present an empirical investigation to detect important factors influencing exporting 
herbal supplements. The proposed study designs a questionnaire consists of 31 questions, 
distributes it among 210 experts who are professional in the area of production and distribution 
of herbal supplements and using factor analysis, the study detects eight factors including 
supportive laws and regulations, organizational atmosphere, marketing structure, knowledge 
oriented, feasibility study, research and development, competitive strategy and partnership 
strategies.       
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1. Introduction 
During the past few years, there have been growing interests in business development of herbal 
supplements in many developing countries especially in Iran. There is a steady demand growth on for 
herbal supplements in developed countries such as United States (Blumenthal et al., 2006). The 
marketing on herbal supplement has increasing trend specially over the cyber space (Morris & Avorn, 
2003). Herbal supplements are used to cure many deceases such as medicating anxiety (Saeed et al., 
2007; Lakhan & Vieira, 2010), acne, weight loss (Pittler et al., 2005), depression, etc. Ritchie (2007), 
for instance, considered the use of herbal supplements and nutritional supplements in the UK. Herbal 
supplements can also be considered as a potential for drug interactions in transplant recipients 
(Barone, et al., 2001). Even, there are some promises on medicating serious deceases such as cancer 
or liver decease using herbal supplements (Kumar et al., 2005; Levy et al., 2004; Temple et al., 2005; 
Kuhn & Winston, 2000). In fact, some researchers believe herbal supplement can be an alternative for 
adverse interactions with analgesic drugs (Abebe, 2002). However, there seems to be a word of  
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cautious on relying herbal supplement for curing serious cancer deceases (Cassidy, 2003) and robust 
clinical trials are needed to prove the efficacy and lack of adverse impacts of such preparations.  
According to (Harrison et al., 2004), more than one in ten adults were taking herbal supplements, 
with evening primrose oil, the most common supplement, applied primarily by women. Individual 
characteristics such as age, gender, ethnicity, and social class influenced the use of herbal 
supplements, but there was no evidence that this substituted for conventional medical care. There was 
also a weak evidence to support some popular herbal supplements. During the past few years, there 
was growing trend on easing regulation on herbal supplement (Gottlieb, 2000; Sahoo et al., 2010) and 
this has helped business owners to spend more on this market.  
2. The proposed study 
In this paper, we present an empirical investigation to detect important factors influencing exporting 
herbal supplements. The proposed study designs a questionnaire consists of 31 questions, distributes 
it among 210 experts who are professional in the area of production and distribution of herbal 
supplements. Cronbach alpha has been calculated as 0.81, which is well above the minimum 
acceptable limit of 0.70. In addition, Kaiser-Meyer-Olkin Measure of Sampling Adequacy and 
Bartlett's Test of Sphericity are calculated as 0.788, 1677.307, respectively. We first present details of 
some basic statistics associated with the data, which are summarized in Table 1 as follows, 
Table 1 
The summary of some basic statistics associated with the questionnaire 
  Variance   Skewness    Kurtosis  
Statistic   Statistic   Std. Error   Statistic   Std. Error  
Competitive challenge  5.722   -.517   .138   -.564   .276  
Competitiveness of existing firms  4.240   -.357   .138   -.131   .276  
Supporting manufacturer  5.485   -.370   .138   -.581   .276  
Lobby with stakeholders  5.262   -.119   .138   -.517   .276  
Insurance Research  4.901   -.108   .138   -.604   .276  
Commercial risk  5.301   -.120   .138   -.660   .276  
Distribution channels  5.939   -.174   .138   -.781   .276  
Material suppliers  5.506   -.126   .138   -.850   .276  
Commercialization process model  5.703   -.187   .138   -.749   .276  
Success in the experimental stage  4.982   -.101   .138   -.520   .276  
Marketing Research  4.969   -.094   .138   -.568   .276  
Financial Feasibility  5.536   -.081   .138   -.776   .276  
Technical feasibility  6.108   .007   .138   -.882   .276  
Research sector and industry  6.123   .002   .138   -.932   .276  
Standard challenges in new markets  6.083   -.056   .138   -.887   .276  
Government incentives  6.332   .000   .138   -.909   .276  
Legal Terms  5.964   .059   .138   -.816   .276  
Intellectual Property  5.650   .056   .138   -.745   .276   
National Planning  5.497   -.125   .138   -.672   .276  
Advanced Technology  6.688   -.009   .138   -.983   .276  
Technical experts  6.768   -.275   .138   -.985   .276  
Nanotechnology  6.043   -.174   .138   -.796   .276  
Organizational structure  5.948   -.370   .138   -.647   .276  
Risk  5.694   -.169   .138   -.731   .276  
Management Support  5.880   -.222   .138   -.782   .276  
Provide timely product  6.569   -.281   .138   -.890   .276  
Market Forecast  5.848   -.339   .138   -.698   .276  
Pricing Strategies  5.832   -.156   .138   -.827   .276  
Market elasticity  5.347   -.272   .138   -.590   .276  
Entrepreneurial environment.  5.840   -.033   .138   -.824   .276  
Positioning the company  6.152   -.254   .138   -.776   .276  
 
We plan to use factor analysis and since this method is sensitive to skewness of the data, we have 
decided to remove some questions from the survey. In addition, Table 2 shows details of 
communalities and as we can observe from the results of our investigation, the average of 
communalities is equal to 0.445, which is within acceptable limit.  N. Hajmirzahosseini Yazdi et al.   / Management Science Letters 4 (2014) 
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Table 2 
The summary of communalities 
  Initial Extraction
Competitive challenge  1.000 .482
Competitiveness of existing firms  1.000 .445
Supporting manufacturer  1.000 .522
Lobby with stakeholders  1.000 .445
Insurance Research  1.000 .475
Commercial risk  1.000 .459
Distribution channels  1.000 .513
Material suppliers  1.000 .616
Commercialization process model  1.000 .520
Success in the experimental stage  1.000 .534
Marketing Research  1.000 .473
Financial Feasibility  1.000 .489
Technical feasibility  1.000 .481
Research sector and industry  1.000 .479
Standard challenges in new markets 1.000 .546
Government incentives  1.000 .612
Legal Terms  1.000 .447
Intellectual Property  1.000 .477
National Planning  1.000 .451
Advanced Technology  1.000 .642
Technical experts  1.000 .619
Nanotechnology  1.000 .489
Organizational structure  1.000 .608
Risk  1.000 .676
Management Support  1.000 .524
Provide timely product  1.000 .488
Market Forecast  1.000 .556
Pricing Strategies  1.000 .493
elasticity of market  1.000 .517
Entrepreneurial environment.  1.000 .485
Positioning the company  1.000 .653
 
In order to extract important factors we first look at Scree plot demonstrated in Fig. 1 as follows, 
 
Fig. 1. Scree plot 
The results of Scree plot shown in Fig. 1 indicate that there are eight important factors. Table  3 
demonstrates the results of factor analysis.  
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Table 3 
The summary of factor analysis after rotation 
Variable  Component  
1   2   3   4   5   6   7   8   9  
Government incentives  .727                  
Standard challenges in new markets  .691                  
Intellectual Property  .569                  
Legal Terms  .533                   
Research sector and industry  .526           .394        
National Planning  .498     .349              
Advanced Technology  .492          .492          
Technical feasibility  .402        .361            
Risk    .792                 
Entrepreneurial environment    .625                
Organizational structure    .579       .344          
Management Support    .512   .353              
Market elasticity      .656              
Pricing Strategies       .615              
Provide timely product      .560               
Financial Feasibility        .628            
Marketing Research        .605            
Material suppliers        .476       .460      
Technical experts          .772          
Nanotechnology          .640          
Market Forecast  .349     .353     -.384          
Success in the experimental stage            .685        
Commercialization process model            .589        
Competitive challenge              .656      
Competitiveness of existing firms              .619      
Distribution channels            .385   .424       
Supporting manufacturer                .634    
Insurance Research                .572    
Lobby with stakeholders                .533    
Commercial risk                .343    
Positioning the company                     .797  
Extraction Method: Principal Component Analysis.   
 Rotation Method: Varimax with Kaiser Normalization.  
a. Rotation converged in 10 iterations.  
 
Based on the results of Table 4, there are eight important factors including supportive laws and 
regulations, organizational atmosphere, marketing structure, knowledge oriented, feasibility study, 
research and development, competitive strategy and partnership strategies. Using factor analysis, we 
can verify each of these eight factors and Table 5 summarizes the results of our investigation. 
Table 5 
The summary of testing all hypotheses 
Row Alternative  Hypothesis  p Estimate Reject the hypothesis Accepting the 
1  Government incentives  P<0.001 1 Accept
2  Standard challenges in new markets 0.112  0.202  Reject 
3  National Planning  P<0.001  1.527  Accept 
4 Legal  Terms  P<0.001  1.511  Accept 
5  Intellectual Property  P<0.001  1.522  Accept 
6 Organizational  structure P<0.001  0.947  Accept 
7  Provide timely product  P<0.001  0.96  Accept 
8 Market  Forecast  P<0.001  0.919  Accept 
9  Financial Feasibility  P<0.001  1  Accept 
10 Marketing  Research P<0.001  1.042  Accept 
11  Technical feasibility  P<0.001  0.935  Accept 
12 Entrepreneurial  environment P<0.001 1  Accept 
13  Risk  P<0.001  1.073  Accept 
14 Management  Support  P<0.001 1.06  Accept 
15  Market elasticity  P<0.001  1  Accept 
16 Pricing  Strategies P<0.001  1.033  Accept 
17  Advanced Technology  P<0.001  1  Accept 
18 Technical  experts  P<0.001 0.895  Accept 
19  Nanotechnology  P<0.001  0.788  Accept 
20  Research sector and industry  P<0.001  1  Accept 
21  Success in the experimental stage  P<0.001  1.127  Accept 
22 Commercialization  process model  0.091  0.228  Reject 
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As we can observe from the results of Table 5, expect two cases, all other hypotheses are confirmed 
and Table 6 summarizes the results of our investigation. 
Table 6 
The summary of six factors and their sub-components 
Factor  Variable  Important	coefficient 
Subsidiary Rules (1.1) 
Intellectual Property  0.6 
Legal Terms  0.59 
National Planning  0.59 
Organizational climate (1.03) 
Management Support  0.65 
Entrepreneurial environment  0.61 
Risk  0.6 
Organizational structure  0.54 
Marketing organization (0.94) 
Marketing Research  0.64 
Financial Feasibility  0.61 
Technical feasibility  0.57 
Knowledge (0.88) 
Advanced Technology  0.67 
Technical experts  0.65 
Nanotechnology  0.57 
Market Survey (0.78) 
Pricing Strategy  0.7 
Market Forecast  0.63 
Provide timely product  0.63 
Market elasticity  0.62 
Process research and development (0.67) 
Success in the experimental stage  0.59 
Research sector and industry  0.52 
 
As we can observe from the results of Table 6, subsidiary rules is the most important factor followed 
by organizational climate, marketing organization, knowledge, market survey and research and 
development.  
4. Conclusion 
In this paper, we have presented an empirical investigation to detect important factors influencing 
export of Iranian herbal supplements. The proposed study has performed a comprehensive review on 
different items and using factor analysis, the study detected six factors influencing this industry. We 
hope the results of our study could help experts find major barriers in exporting herbal supplements 
and expand this market. In our survey, subsidiary rules were considered the most important item and 
the government needs to take the necessary actions on changing the rules and regulations on helping 
this industry grow. Marketing climate was the second most important factor and the experts are 
suggested to cooperate with public media to create more awareness on the advantages of exporting 
herbal supplements. 
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